This project will utilize highly developed libraries of antibody probes to neurofilament proteins and to cytoskeletal enzymes which modulate neurofilament proteins (i.e., calcium-activated neutral protease and calcium-activated transglutaminase) in order to characterize and compare the changes in the neuronal cytoskeleton which occur during maturation and aging of the neuron in experimental pathological and dysfunctional states and in neurodegenerative diseases such as pathological and dysfunctional states and in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Attention will be directed at the alterations of cytoskeletal proteins which may account for the accumulations of neurofilaments and/or their immunoreactive products in pathological and disease states. Mechanisms of change will be sought by examining the reactive changes in neurofilament proteins and the associated cytoskeletal enzymes in neurons which have been injured experimentally by axonal transection. Immunohistochemical and immunobiochemical methods will be used to assess the distributions of the different cytoskeletal proteins, their localization within the neuron as well as their varying amounts and forms within the tissues. The Program Project will apply concepts and methods from basic neurobiology to elucidate pathological and disease states of the neuron. It is hoped that these efforts will provide new insights and understandings on the nature of the neuronal cytoskeleton, its alteration during development and aging and its role in determining the manifestations of neuronal dysfunction and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG006107-01A1
Application #
3091059
Study Section
Aging Review Committee (AGE)
Project Start
1987-01-01
Project End
1989-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Joyce, J N; Hurtig, H (1990) Differential regulation of striatal dopamine D1 and D2 receptor systems in Parkinson's disease and effects of adrenal medullary transplant. Prog Brain Res 82:699-706
Stern, R A; Trojanowski, J Q; Lee, V M (1990) Antibodies to the beta-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood. FEBS Lett 264:43-7
Ksiezak-Reding, H; Chien, C H; Lee, V M et al. (1990) Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J Neurosci Res 25:412-9
Schmidt, M L; Lee, V M; Trojanowski, J Q (1990) Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am J Pathol 136:1069-75
Arai, H; Lee, V M; Otvos Jr, L et al. (1990) Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci U S A 87:2249-53
Trojanowski, J Q; Schuck, T; Schmidt, M L et al. (1989) Distribution of phosphate-independent MAP2 epitopes revealed with monoclonal antibodies in microwave-denatured human nervous system tissues. J Neurosci Methods 29:171-80
Trojanowski, J Q; Schmidt, M L; Otvos Jr, L et al. (1989) Selective expression of epitopes in multiphosphorylation repeats of the high and middle molecular weight neurofilament proteins in Alzheimer neurofibrillary tangles. Ann Med 21:113-6
Hurtig, H; Joyce, J; Sladek Jr, J R et al. (1989) Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol 25:607-14
Stern, R A; Otvos Jr, L; Trojanowski, J Q et al. (1989) Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease beta-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol 134:973-8
Schmidt, M L; Lee, V M; Trojanowski, J Q (1989) Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus. Lab Invest 60:513-22

Showing the most recent 10 out of 22 publications